Clinically, breast cancer is classified into three major subtypes: hormone receptor-positive (HR+), human epidermal growth factor receptor two-positive (HER2+), and triple-negative (TN) breast cancer (Goldhirsch et al., 2011; Natori et al., 2023). This evidence concerns the gene NR4A1 and breast carcinoma.